RegisterLogin

KB-0118

CAT: 0931-T211196-01Size: 10 mgDry Ice: NoHazardous: No
CAT#:0931-T211196-01Size:10 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
CAS Number
2648377-08-4
Target
Interleukin|||STAT|||Epigenetic Reader Domain
Related Pathways
Chromatin/Epigenetic|||JAK/STAT signaling|||Stem Cells|||Immunology/Inflammation
Bioactivity
KB-0118 (BBC0115) is an inhibitor targeting the BET bromodomain. It selectively binds to BRD2 and BRD4, with dissociation constants (Kd) of 36.7 ?M for BRD2 BD1 and 47.4 ?M for BRD4 BD1, while not binding to BRD3. KB-0118 suppresses the secretion of pro-inflammatory cytokines such as TNF, IL-1?, and IL-23a, and selectively inhibits Th17 cell differentiation. The compound regulates Th17-driven inflammation through the epigenetic suppression of BRD4, as evidenced by the downregulation of STAT3 and BRD4 target genes. Additionally, KB-0118 exhibits immunomodulatory effects in inflammatory bowel disease (IBD) models.
Smiles
O=C1C(O)=C(OC=2C=C(O)C=C(O)C12)C=3C=CC=4C=CNC4C3
Molecular Formula
C17H11NO5
Molecular Weight
309.27
Shipping Conditions
Cool pack
Storage Temperature
-20°C

Related Products

CatalogName
T26689-01AVE-0118
T131221-01Compound N060-0118
T131685-01Compound 0118-0250
T131686-01Compound 0118-0244
T32368-01KB-74935
T212527-01KB-15
T27713-01KB-130015
T70280KB-R7785
T24255-01KB 5666
T27714-01KB-141

Alternative Products

CatalogName
HY-176535KB-0118
M14669-01AVE-0118
MBS5796617Compound 0118-0250
IL-0118-HP-BULKIoLiLyt 0118
MBS5796618Compound 0118-0244
MBS5796159Compound N060-0118
IL-0118-HP-0025IoLiLyt 0118, 25 g
IL-0118-HP-0050IoLiLyt 0118, 50 g
IL-0118-HP-0500IoLiLyt 0118, 500 g
IL-0118-HP-0100IoLiLyt 0118, 100 g

Popular Products